We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
(-13%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-18.41%
Top 10 Holdings %
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$31.9M |
| 2 |
GE HealthCare
GEHC
|
+$31.5M |
| 3 |
ImmunityBio
IBRX
|
+$20.9M |
| 4 |
GitLab
GTLB
|
+$14.8M |
| 5 |
Verastem
VSTM
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$52.3M |
| 2 |
Spectrum Brands
SPB
|
+$49.4M |
| 3 |
Simply Good Foods
SMPL
|
+$46.6M |
| 4 |
Boston Beer
SAM
|
+$42M |
| 5 |
Domino's
DPZ
|
+$41.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.42% |
| 2 | Consumer Discretionary | 5.85% |
| 3 | Technology | 4.99% |
| 4 | Consumer Staples | 1.48% |
| 5 | Communication Services | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ferguson
FERG
$49.4B
| – | – |
-24,000
| Closed | -$3.85M |
|
227
Globus Medical
GMED
$10.9B
| – | – |
-172,823
| Closed | -$12.7M |
|
228
GeoVax Labs
GOVX
$3.91M
| – | – |
-26,515
| Closed | -$703K |
|
229
GSK
GSK
$103B
| – | – |
-378,000
| Closed | -$14.6M |
|
230
Helen of Troy
HELE
$689M
| – | – |
-371,000
| Closed | -$19.8M |
|
231
Solana Company
HSDT
$100M
| – | – |
-96
| Closed | -$28.9K |
|
232
Humana
HUM
$43.7B
| – | – |
-56,023
| Closed | -$14.8M |
|
233
Icon
ICLR
$12.6B
| – | – |
-100,052
| Closed | -$17.5M |
|
234
SeaStar Medical
ICU
$12M
| – | – |
-61,324
| Closed | -$1.02M |
|
235
T Stamp
IDAI
$17.2M
| – | – |
-130,000
| Closed | -$252K |
|
236
CALL
Immunovant
IMVT
$8B
| – | – |
-900,000
| Closed | -$15.4M |
|
237
Intel
INTC
$517B
| – | – |
-20,603
| Closed | -$468K |
|
238
Intensity Therapeutics
INTS
$11.4M
| – | – |
-34,902
| Closed | -$1.72M |
|
239
Professional Diversity Network
IPDN
$5.21M
| – | – |
-113,453
| Closed | -$285K |
|
240
Keurig Dr Pepper
KDP
$41.6B
| – | – |
-1,099,716
| Closed | -$37.6M |
|
241
Las Vegas Sands
LVS
$29.8B
| – | – |
-120,822
| Closed | -$4.67M |
|
242
Moleculin Biotech
MBRX
$2.79M
| – | – |
-50,000
| Closed | -$1.22M |
|
243
Magnite
MGNI
$2.96B
| – | – |
-389,000
| Closed | -$4.44M |
|
244
Merck
MRK
$317B
| – | – |
-324,039
| Closed | -$29.1M |
|
|
MURA
245
DELISTED
Mural Oncology
MURA
| – | – |
-1,722,000
| Closed | -$2.17M |
|
246
Murphy USA
MUSA
$10.7B
| – | – |
-12,408
| Closed | -$5.83M |
|
|
NB
247
NioCorp Developments
NB
$734M
| – | – |
-1,306,273
| Closed | -$2.57M |
|
248
Nike
NKE
$62.8B
| – | – |
-173,451
| Closed | -$11M |
|
249
Nomad Foods
NOMD
$1.65B
| – | – |
-1,025,064
| Closed | -$20.1M |
|
|
NVO
250
Novo Nordisk
NVO
$197B
| – | – |
-108,000
| Closed | -$7.5M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.
- Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
- Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
- Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
- Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
- Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
- Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
- Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.
Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.